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Abstract o-Phthalaldehyde (OPA) reacts with O-protected tris(hy-
droxyalkyl)aminomethanes in the presence of 1-propanethiol to afford
a novel class of stable isoindoles. Steric protection provided by the bulk-
iness of C3-symmetric primary amines derived from tris(hydroxymeth-
yl)aminomethane could be significant for the stabilization of 1-alk-
ylthio-2-alkyl-substituted isoindoles derived from OPA. A plausible
reaction mechanism is proposed to explain the formation of the isoin-
dole and an isoindolin-1-one by-product.
Key words o-phthalaldehyde, isoindole, steric protection, isoindolin-
1-one
Benzo[c]pyrrole, also called isoindole,1 is a regioisomer
of benzo[b]pyrrole or, more commonly, indole. In 1971,
Roth reported that o-phthalaldehyde (OPA) reacted with
amino acids in alkaline medium in the presence of 2-mer-
captoethanol to furnish 1-alkylthio-2-alkyl-substituted iso-
indoles (Scheme 1).2 As the resultant isoindole is sensitively
detected by its fluorescence (λex = 360 nm, λem = 455 nm),
the three-component coupling reaction is generally used as
one of the most valuable methods of analyzing primary
amines including amino acids.3,4 In the OPA method men-
tioned above, the intrinsically nonfluorescent property of
OPA is advantageous to the analysis of primary amines,
while a drawback is the instability of the resulting 1-alk-
ylthio-2-alkyl-substituted isoindoles, despite isoindole hav-
ing a 10π-electron aromatic system. It is said that the steric
bulk of the side chains derived from thiols and amines, such
as tert-butylamine and tert-butylthiol, increases the stabili-
ty of the isoindoles.5 In general, appropriate steric protec-
tion of organic molecules is an effective strategy for stabili-
zation.6,7 However, from a synthetic point of view, the stabi-
lization effects of these reagents are insufficient to isolate
the resulting 1-alkylthio-2-alkyl-substituted isoindoles in
pure forms. To the best of our knowledge, few reports are
available on the synthesis of stable and isolable 1-alkylthio-
2-alkyl-substituted isoindoles based on the OPA method. In
2012, Sipos et al. reported the synthesis and biological ac-
tivities of isoindole and benzoisoindole derivatives of glyco-
peptide antibiotics, which have large molecular sizes and
function as primary amines in the OPA method.8 In this pa-
per, we report on the synthesis of sterically protected 1-al-
kylthio-2-alkyl-substituted isoindoles using C3-symmetric
bulky amines derived from tris(hydroxyalkyl)aminometh-
ane based on the OPA method. HPLC analysis of a mixture of
stable isoindoles derived from alkyl thiols, OPA, and O-ben-
zylated tris(hydroxypropyl)aminomethane was also con-
ducted.
Scheme 1  The reaction of OPA with a primary amine and thiol
A novel series of 1-alkylthio-2-alkyl-substituted isoin-
doles, which are stable enough to be isolated, has been de-
signed and synthesized, making use of C3-symmetric pri-
mary amines in the OPA method. The C3-symmetric prima-
ry amines employed in this study were chosen to enhance
the steric protection effect in isoindole molecules by fur-
ther increasing the steric bulk of the tert-butylamine. Thus,
a series of C3-symmetric primary amines 5a–g was pre-
pared from tris(hydroxymethyl)aminomethane (1) or
tris(hydroxypropyl)aminomethane (2), as shown in Scheme
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synthesized from 1 using benzyl bromide according to a
modified procedure.9 O-Alkylation of 3 with alkyl iodides
followed by hydrogenolysis catalyzed by palladium on acti-
vated charcoal (Pd-C) gave primary amines 5a and 5b, re-
spectively. N-Boc-tris(hydroxymethyl)aminomethane (6),10
obtained from 1, was O-alkylated by the corresponding al-
kyl chlorides to afford N-Boc-protected amines 7c–e.
Deprotection of 7c–e using trifluoroacetic acid (TFA) gave
primary amines 5c–e. O-Benzylated amine 5f was also syn-
thesized from 2 according to a similar procedure used for
the preparation of 5c–e. In addition, reaction of 3 with tri-
ethyl orthoacetate followed by removal of the benzyl
groups by hydrogenolysis furnished 5g,11 which was re-
garded as a less bulky primary amine than the other O-pro-
tected amines 5a–f.
In our attempt to synthesize stable and isolable 1-alk-
ylthio-2-alkyl-substituted isoindoles by the OPA method,
C3-symmetric primary amines 1, 2, and 5a–e were reacted
with OPA and 1-propanethiol in anhydrous MeOH at room
temperature in the dark using brown-tinted glassware as
shown in Table 1. O-Protected amines 5a,b afforded isoin-
doles 11a,b with small amounts of isoindolin-1-ones 12a,b
as by-products (entries 1 and 2). As expected, isoindoles
11a,b were stable and isolable by column chromatography
on silica gel. When amines 5c–e were employed, the isolat-
ed yields of isoindoles 11c–e (54–60%) were relatively low,
and isoindolin-1-ones 12c–e were obtained in 39–44%
yields (entries 3–5). To examine the influence of the oxygen
atom of C3-symmetric amine 5e originating from 1 on
the formation of isoindolin-1-one 12e, O-benzylated
Scheme 2  Synthesis of C3-symmetric primary amines 5a–g starting from tris(hydroxymethyl)aminomethane (1) and tris(hydroxypropyl)amino-
methane (2)
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Table 1  Synthesis of 1-Alkylthio-2-alkyl-Substituted Isoindoles 11a–i 
by the OPA Methoda
Entry X Yield of 11 (%)b Yield of 12 (%)b
1 OMe (5a) 65 (11a) 18 (12a)
2 OEt (5b) 85 (11b) 12 (12b)
3 OMOM (5c) 57 (11c) 41 (12c)
4 OMEM (5d) 54 (11d) 44 (12d)
5 OBOM (5e) 60 (11e) 39 (12e)
6 (CH2)2OBn (5f) 93 (11f) ca. 6 (12f)c
7 orthoester (5g) –d (11g) 0 (12g)
8 OH (1) –d (11h) 0 (12h)
9 (CH2)2OH (2) 90 (11i) 0 (12i)
10e OMOM (5c) – (11c) 56 (12c)
11e (CH2)2OH (2) – (11i) 0 (12i)
a Reaction conditions: OPA (1 equiv), 1-propanethiol (1.1 equiv), amine 
(1.1 equiv).
b Isolated yield.
c Small amounts of impurities were included.
d Too labile to be isolated.
e Reaction without 1-propanethiol.
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OPA and 1-propanethiol. As a result, 5f afforded isoindole
11f in 93% yield and isoindolin-1-one 12f in ca. 6% yield
(entry 6). On the other hand, isoindole 11g, synthesized
from less bulky amine 5g, was too labile to be isolated (en-
try 7). In the reaction of triols 1 and 2, the 1-alkylthio-2-
alkyl-substituted isoindoles 11h and 11i were also ob-
tained, but 11h decomposed immediately after isolation by
column chromatography on silica gel (entries 8 and 9). In
addition, the reaction of OPA with amine 5c in the absence
of 1-propanethiol was relatively slow and afforded isoindo-
lin-1-one 12c in 56% yield (entry 10). In the reaction of 2
and OPA without 1-propanethiol, isoindolin-1-one 12i was
not obtained at all (entry 11). When isoindole 11c, instead
of OPA, was placed under the same reaction conditions as
those noted in entry 3, 86% yield of 11c was recovered
without production of 12c. Thus, the formation of isoindo-
lin-1-one 12c is presumed not to be attributable to the hy-
drolysis of 11c under these reaction conditions.
Based on these results, plausible reaction pathways for
the formation of isoindoles 11a–e (route A) and isoindolin-
1-ones 12a–e (route B) have been proposed (Scheme 3).
Route A is the standard pathway for the three-component
coupling reaction based on the OPA method.5 On the other
hand, neighboring group participation by an oxygen atom
of the ether bond of each of amines 5a–e is involved in
route B. In this case, the formation of the five-membered
1,3-oxazolidin-1-ium intermediate by intramolecular cy-
clization prevents intermolecular nucleophilic attack of 1-
propanethiol. The ratios of the products of 11a–e and 12a–
e seem to depend on the bond angle θ (N-C-C) of the corre-
sponding C3-symmetric primary amines 5a–e. Amines 5c–
e, which are presumed to have smaller θ values compared
with 5a and 5b, are liable to follow pathway B. In the case of
amine 5f, in which three oxygen atoms of 5e are replaced
by three methylene units, this kind of neighboring group
participation of an oxygen atom via a seven-membered 1,3-
oxazepan-1-ium intermediate might be difficult to achieve.
Furthermore, 1-octanethiol and 1-dodecanethiol readily
reacted with OPA and 5f to afford stable and isolable isoin-
doles 11j and 11k in 96% and 91% yields, respectively. To
provide some preliminary data on the application as a novel
method of analyzing thiols, HPLC analysis of an equimolar
mixture of isoindoles 11f, 11j, and 11k was investigated
with an ODS column. The results showed that isoindoles
11f, 11j, and 11k were easily resolved from one another, as
shown in Figure 1. The area ratio for these three peaks de-
rived from isoindoles 11f, 11j, and 11k (32.35:33.94:33.18)
was almost identical to the respective molar ratio (1:1:1).
In summary, we have synthesized a novel series of 1-al-
kylthio-2-alkyl-substituted isoindoles 11a–f and 11i–k by
the three-component coupling reaction of OPA, thiols (1-
propanethiol, 1-octanethiol, and 1-dodecanthiol), and C3-
symmetric bulky amines 2 and 5a–f. These isoindoles were
stable enough to be isolated by column chromatography
over silica gel. To the best of our knowledge, this is the first
report of the synthesis of stable and isolable isoindoles
based on the OPA method using modest molecular weight
amines. Efforts toward the development of a novel analytical
Scheme 3  Plausible reaction pathways for the formation of 11a–e and 12a–e
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Figure 1  HPLC analysis for resolution of a mixture of isoindoles 11f, 
11j, and 11k formed from 1-propanethiol, 1-octanethiol, and 1-dodec-
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protected isoindoles based on the OPA method are under
way.
All melting points were determined with a Yanagimoto micro melting
point apparatus and are uncorrected. IR spectra were obtained with a
JASCO FT/IR-6200 IR Fourier transform spectrometer. 1H NMR (500
MHz) and 13C NMR (125 MHz) spectra were recorded with a Bruker
AV500 spectrometer. Chemical shifts are given in δ values (ppm) us-
ing TMS as an internal standard. HRMS (ESI) were recorded with a
Waters LCT Premier spectrometer. Elemental combustion analyses
were performed with a J-SCIENCE LAB JM10 microcorder. All reac-
tions were monitored by TLC employing 0.25 mm silica gel plates
(Merck 5715; 60 F254). Column chromatography was carried out on
silica gel [Silica Gel 60N (Kanto Chemical) or Silica Gel PSQ 60B (Fuji
Silysia Chemical)]. Anhydrous THF, CH2Cl2, DMF, and toluene were
used as purchased from Kanto Chemical. All other reagents were used
as purchased.
N,N-Dibenzyl-1,3-dimethoxy-2-(methoxymethyl)propan-2-amine 
(4a)
To a suspension of NaH (50–72% in mineral oil, 394 mg, 8.21–11.8
mmol) in anhydrous DMF (5 mL) was added 3 (900 mg, 2.99 mmol) in
anhydrous DMF (5 mL) and MeI (614 μL, 9.85 mmol). The reaction
mixture was stirred at r.t. for 4 h under argon. H2O (10 mL) was added
and the reaction mixture was extracted with EtOAc (50 mL). The or-
ganic layer was washed with H2O (3 × 20 mL), dried (MgSO4), filtered,
and concentrated in vacuo. The oily residue was purified by column
chromatography [silica gel 60N; n-hexane–EtOAc, 9:1] to afford 4a.
Yield: 922 mg (90%); pale-yellow oil.
IR (neat): 3026, 2980, 2889, 2810, 2059, 1946, 1869, 1810, 1603,
1453, 1107 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.27–7.26 (m, 4 H), 7.16–7.13 (m, 4 H),
7.08–7.05 (m, 2 H), 3.98 (s, 4 H), 3.52 (s, 6 H), 3.25 (s, 9 H).
13C NMR (125 MHz, CDCl3): δ = 142.4, 128.4, 127.6, 126.0, 73.6, 64.0,
59.1, 54.8.
HRMS (ESI): m/z [M + Na]+ calcd for C21H29NO3Na: 366.2045; found:
366.2031.
Anal. Calcd for C21H29NO3: C, 73.44; H, 8.51; N, 4.08. Found: C, 73.15;
H, 8.65; N, 4.09.
N,N-Dibenzyl-1,3-diethoxy-2-(ethoxymethyl)propan-2-amine 
(4b)
Synthesized from 3 and ethyl iodide according to the procedure used
to prepare 4a.
Yield: 467 mg (84%); pale-yellow oil.
IR (neat): 2974, 2867, 1494, 1454, 1377, 1113 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.29–7.26 (m, 4 H), 7.15–7.12 (m, 4 H),
7.07–7.04 (m, 2 H), 4.00 (s, 4 H), 3.55 (s, 6 H), 3.38 (q, J = 7.0 Hz, 6 H),
1.16 (t, J = 7.0 Hz, 9 H).
13C NMR (125 MHz, CDCl3): δ = 142.8, 128.4, 127.5, 125.8, 71.3, 66.6,
64.1, 54.8, 15.2.
HRMS (ESI): m/z [M + Na]+ calcd for C24H35NO3Na: 408.2515; found:
408.2504.
Anal. Calcd for C24H35NO3: C, 74.77; H, 9.15; N, 3.63. Found: C, 74.62;
H, 9.31; N, 3.58.
1,3-Dimethoxy-2-(methoxymethyl)propan-2-amine (5a)
A mixture of 4a (270 mg, 0.790 mmol) and 10% Pd/C (84.0 mg, 0.0790
mmol) in MeOH (10 mL) was stirred at r.t. for 1.5 h under H2 atmo-
sphere. The reaction mixture was filtered and concentrated in vacuo.
The residue was dissolved in CHCl3 (30 mL) and washed with sat. aq
NaHCO3 (20 mL). The organic layer was dried (MgSO4), filtered, and
concentrated in vacuo to afford 5a.
Yield: 118 mg (91%); pale-yellow oil.
IR (neat): 3383, 2980, 2892, 2814, 1456, 1109 cm–1.
1H NMR (500 MHz, CDCl3): δ = 3.35 (s, 9 H), 3.29 (s, 6 H), 1.52 (br s,
2 H).
13C NMR (125 MHz, CDCl3): δ = 75.0, 59.4, 55.7.
HRMS (ESI): m/z [M + Na]+ calcd for C7H17NO3Na: 186.1106; found:
186.1091.
1,3-Diethoxy-2-(ethoxymethyl)propan-2-amine (5b)
Synthesized from 4b according to the procedure used to prepare 5a.
Yield: 170 mg (91%); pale-yellow oil.
IR (neat): 3385, 2976, 2867, 1110, 864 cm–1.
1H NMR (500 MHz, CDCl3): δ = 3.49 (q, J = 7.0 Hz, 6 H), 3.33 (s, 6 H),
1.55 (br s, 2 H), 1.17 (t, J = 7.0 Hz, 9 H).
13C NMR (125 MHz, CDCl3): δ = 72.6, 66.8, 55.7, 15.1.
HRMS (ESI): m/z [M + Na]+ C10H23NO3Na: 228.1576; found: 228.1565.
tert-Butyl [1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl]carba-
mate (6)10b
To a solution of 1 (2.00 g, 16.5 mmol) in t-BuOH (27.5 mL)/MeOH
(12.5 mL) was added di-tert-butyl dicarbonate (4.70 g, 21.5 mmol).
After stirring for 18 h at r.t., the reaction mixture was evaporated in
vacuo and the residue was washed with cool EtOAc to afford 6.
Yield: 3.52 g (96%); white solid; mp 142.7–145 °C (colorless needles,
EtOAc).
IR (KBr): 3300, 2962, 1680, 1549, 1468, 1369, 1296, 1176 cm–1.
1H NMR (500 MHz, DMSO-d6): δ = 5.76 (br s, 1 H), 4.50 (t, J = 5.3 Hz,
3 H), 3.51 (d, J = 5.6 Hz, 6 H), 1.37 (s, 9 H).
13C NMR (125 MHz, DMSO-d6): δ = 154.9, 77.7, 60.3, 60.1, 28.1.
HRMS (ESI): m/z [M + Na]+ calcd for C9H19NO5Na: 244.1161; found:
244.1141.
Anal. Calcd for C9H19NO5: C, 48.86; H, 8.66; N, 6.33. Found: C, 48.73;
H, 8.68; N, 6.31.
tert-Butyl {6-[(Methoxymethoxy)methyl]-2,4,8,10-tetraoxaunde-
can-6-yl}carbamate (7c)
To a solution of 6 (500 mg, 2.26 mmol) and DIPEA (1.30 mL, 7.46
mmol) in anhydrous THF (6.6 mL) was added MOMCl (0.790 mL, 7.46
mmol). After stirring for 2 h at r.t., DIPEA (1.30 mL, 7.46 mmol) and
MOMCl (0.790 mL, 7.46 mmol) were added to the reaction mixture.
After stirring for a further 2 h at r.t., DIPEA (1.30 mL, 7.46 mmol) and
MOMCl (0.790 mL, 7.46 mmol) were again added to the reaction mix-
ture. After stirring for a final 2 h at r.t., the reaction mixture was evap-
orated in vacuo. The residue was dissolved in EtOAc (50 mL) and
washed with brine (2 × 20 mL). The organic layer was dried (Na2SO4),
filtered, and concentrated in vacuo. The oily residue was purified by
column chromatography [silica gel PSQ 60B; n-hexane–EtOAc, 2:1] to
afford 7c.
Yield: 796 mg (100%); pale-yellow oil.Georg Thieme Verlag  Stuttgart · New York — SynOpen 2018, 2, 50–57
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M. Nakao et al. PaperSyn OpenIR (neat): 3450, 3359, 2934, 2889, 2824, 1718, 1502, 1366, 1245,
1150, 1112, 1047 cm–1.
1H NMR (500 MHz, CDCl3): δ = 5.03 (br s, 1 H), 4.63 (s, 6 H), 3.82 (s,
6 H), 3.36 (s, 9 H), 1.42 (s, 9 H).
13C NMR (125 MHz, CDCl3): δ = 154.7, 96.8, 79.1, 67.1, 57.8, 55.3, 28.3.
HRMS (ESI): m/z [M + Na]+ calcd for C15H31NO8Na: 376.1947; found:
376.1922.
Anal. Calcd for C15H31NO8: C, 50.98; H, 8.84; N, 3.96. Found: C, 50.68;
H, 8.83; N, 4.02.
tert-Butyl (9-{[(2-Methoxyethoxy)methoxy]methyl}-
2,5,7,11,13,16-hexaoxaheptadecan-9-yl)carbamate (7d)
Synthesized from 6 and MEMCl according to the procedure used to
prepare 7c.
Yield: 576 mg (87%); pale-yellow oil.
IR (neat): 3450, 3348, 2931, 2885, 1716, 1500, 1456, 1366, 1246,
1173, 1116, 1045 cm–1.
1H NMR (500 MHz, CDCl3): δ = 5.08 (br s, 1 H), 4.71 (s, 6 H), 3.82 (s,
6 H), 3.69–3.67 (m, 6 H), 3.56–3.54 (m, 6 H), 3.39 (s, 9 H), 1.41 (s, 9 H).
13C NMR (125 MHz, CDCl3): δ = 154.7, 95.9, 79.1, 71.7, 67.3, 66.9, 59.0,
57.9, 28.3.
HRMS (ESI): m/z [M + Na]+ calcd for C21H43NO11Na: 508.2734; found:
508.2727.
tert-Butyl (6-{[(Benzyloxy)methoxy]methyl}-1,11-diphenyl-
2,4,8,10-tetraoxaundecan-6-yl)carbamate (7e)10b
Synthesized from 6 and BOMCl according to the procedure used to
prepare 7c.
Yield: 481 mg (61%); pale-yellow oil.
IR (neat): 3436, 3063, 3032, 2939, 2885, 1716, 1498, 1366, 1170,
1112, 1046 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.34–7.27 (m, 15 H), 5.01 (br s, 1 H),
4.76 (s, 6 H), 4.59 (s, 6 H), 3.91 (s, 6 H), 1.41 (s, 9 H).
13C NMR (125 MHz, CDCl3): δ = 154.7, 137.7, 128.4, 127.9, 127.7, 95.0,
79.2, 69.4, 67.4, 57.9, 28.4.
HRMS (ESI): m/z [M + Na]+ calcd for C33H43NO8Na: 604.2886; found:
604.2878.
6-[(Methoxymethoxy)methyl]-2,4,8,10-tetraoxaundecan-6-amine 
(5c)
To a solution of 7c (400 mg, 1.13 mmol) in anhydrous CH2Cl2 (5.5 mL)
was added TFA (2.00 mL, 26.0 mmol) at 0 °C. After stirring for 50 min
at 0 °C, 2N Na2CO3 (25 mL) was added and the mixture was extracted
with CHCl3 (3 × 30 mL). The combined organic layers were dried (Mg-
SO4), filtered, and concentrated in vacuo. The oily residue was puri-
fied by column chromatography [silica gel PSQ 60B; CHCl3–MeOH,
9:1] to afford 5c.
Yield: 272 mg (95%); pale-yellow oil.
IR (neat): 3378, 2929, 2885, 1587, 1467, 1442, 1403, 1213, 1149,
1110, 1040 cm–1.
1H NMR (500 MHz, CDCl3): δ = 4.64 (s, 6 H), 3.49 (s, 6 H), 3.36 (s, 9 H),
1.56 (br s, 2 H).
13C NMR (125 MHz, CDCl3): δ = 96.8, 69.9, 55.3, 55.2.
HRMS (ESI): m/z [M + Na]+ calcd for C10H23NO6Na: 276.1423; found:
276.1401.
9-{[(2-Methoxyethoxy)methoxy]methyl}-2,5,7,11,13,16-hexaoxa-
heptadecan-9-amine (5d)
Synthesized from 7d according to the procedure used to prepare 5c.
Yield: 193 mg (97%); colorless oil.
IR (neat): 2928, 2881, 1457, 1413, 1365, 1244, 1200, 1117, 1043 cm–1.
1H NMR (500 MHz, CDCl3): δ = 4.72 (s, 6 H), 3.69–3.67 (m, 6 H), 3.56–
3.55 (m, 6 H), 3.50 (s, 6 H), 3.40 (s, 9 H), 1.66 (br s, 2 H).
13C NMR (125 MHz, CDCl3): δ = 95.9, 71.7, 70.1, 66.8, 59.0, 55.4.
HRMS (ESI): m/z [M + Na]+ calcd for C16H35NO9Na: 408.2210; found:
408.2204.
6-{[(Benzyloxy)methoxy]methyl}-1,11-diphenyl-2,4,8,10-tetraox-
aundecan-6-amine (5e)10b
Synthesized from 7e according to the procedure used to prepare 5c.
Yield: 140 mg (84%); pale-yellow oil.
IR (neat): 3379, 3088, 3063, 3031, 2936, 2880, 1586, 1498, 1455,
1381, 1162, 1111, 1041 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.36–7.27 (m, 15 H), 4.77 (s, 6 H), 4.59
(s, 6 H), 3.58 (s, 6 H), 1.62 (br s, 2 H).
13C NMR (125 MHz, CDCl3): δ = 137.7, 128.4, 127.8, 127.7, 95.0, 70.2,
69.4, 55.4.
HRMS (ESI): m/z [M + Na]+ calcd for C28H35NO6Na: 504.2362; found:
504.2313.
tert-Butyl [1,7-Dihydroxy-4-(3-hydroxypropyl)heptan-4-yl]carba-
mate (8)
Synthesized from 2 according to the procedure used to prepare 6.
Yield: 1.62 g (99%); mp 103.7–105 °C (colorless needles, CHCl3).
IR (KBr): 3405, 3305, 3262, 2949, 2873, 1691, 1546, 1454, 1366, 1279,
1166 cm–1.
1H NMR (500 MHz, DMSO-d6): δ = 6.07 (br s, 1 H), 4.36 (t, J = 5.0 Hz,
3 H), 3.34–3.31 (m, 6 H), 1.49–1.47 (m, 6 H), 1.36 (s, 9 H), 1.36–1.27
(m, 6 H).
13C NMR (125 MHz, DMSO-d6): δ = 153.9, 76.7, 61.3, 56.1, 31.0, 28.2,
26.5.
HRMS (ESI): m/z [M + Na]+ calcd for C15H31NO5Na: 328.2100; found:
328.2104.
Anal. Calcd for C15H31NO5: C, 58.99; H, 10.23; N, 4.59. Found: C, 58.69;
H, 10.16; N, 4.53.
tert-Butyl {1,7-Bis(benzyloxy)-4-[3-(benzyloxy)propyl]heptan-4-
yl}carbamate (9)
To a solution of 8 (300 mg, 0.982 mmol) and benzyl bromide (0.760
mL, 6.38 mmol) in anhydrous DMF (1.6 mL) was added KOH (379 mg,
6.75 mmol) at r.t. under argon. The reaction mixture was stirred for
21 h at r.t., for 2 h at 40 °C, and for 2 h at 60 °C. H2O (20 mL) was added
and the mixture was extracted with EtOAc (30 mL). The organic layer
was washed with H2O (2 × 20 mL), dried (Na2SO4), filtered, and con-
centrated in vacuo. The oily residue was purified by column chroma-
tography [silica gel PSQ 60B; n-hexane–EtOAc, 5:1 to 1:1] to afford 9.
Yield: 211 mg (37%); colorless oil.
IR (neat): 3352, 2945, 2856, 1715, 1497, 1454, 1390, 1364, 1248,
1170, 1100, 736, 698 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.35–7.26 (m, 15 H), 4.48 (s, 6 H), 4.42
(br s, 1 H), 3.45 (t, J = 6.4 Hz, 6 H), 1.67–1.65 (m, 6 H), 1.60–1.53 (m,
6 H), 1.39 (s, 9 H).Georg Thieme Verlag  Stuttgart · New York — SynOpen 2018, 2, 50–57
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72.9, 70.6, 56.9, 31.9, 28.4, 23.7.
HRMS (ESI): m/z [M + Na]+ calcd for C36H49NO5Na: 598.3508; found:
598.350.
Anal. Calcd for C36H49NO5: C, 75.10; H, 8.58; N, 2.43. Found: C, 74.80;
H, 8.54; N, 2.60.
1,7-Bis(benzyloxy)-4-[3-(benzyloxy)propyl]heptan-4-amine (5f)
Synthesized from 9 according to the procedure used to prepare 5c.
Yield: 266 mg (99%); yellow oil.
IR (neat): 3061, 3031, 2945, 2855, 1719, 1454, 1361, 1276, 1102 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.38–7.26 (m, 15 H), 4.49 (s, 6 H), 3.45
(t, J = 6.6 Hz, 6 H), 1.63–1.57 (m, 8 H), 1.41–1.38 (m, 6 H).
13C NMR (125 MHz, CDCl3): δ = 138.5, 128.3, 127.6, 127.5, 72.9, 70.9,
52.8, 36.4, 24.0.
HRMS (ESI): m/z [M + Na]+ calcd for C31H41NO3Na: 498.2984; found:
498.2968.
N,N-Dibenzyl-1-methyl-2,6,7-trioxabicyclo[2.2.2]octan-4-amine 
(10)
To a solution of 3 (1.00 g, 3.32 mmol) in toluene (6 mL) was added
triethyl orthoacetate (605 μL, 3.32 mmol) at 0 °C. After stirring for 45
min at 80 °C, for 1.25 h at 100 °C, and for 36 h at 120 °C, the reaction
mixture was evaporated in vacuo. The residue was purified by column
chromatography [silica gel PSQ 60B; n-hexane–CHCl3, 1:9] to afford
10.
Yield: 536 mg (50%); white solid; mp 122–123 °C.
IR (KBr): 3299, 3063, 2969, 2889, 1952, 1875, 1542, 1255, 1042 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.25–7.19 (m, 10 H), 4.07 (s, 6 H), 3.76
(s, 4 H), 1.42 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 139.8, 128.3, 128.1, 127.2, 108.3, 68.6,
53.8, 53.1, 22.9.
1-Methyl-2,6,7-trioxabicyclo[2.2.2]octan-4-amine (5g)11
Synthesized from 10 according to the procedure used to prepare 5a.
Yield: 16.0 mg (73%); white solid; mp 116–117 °C.
IR (KBr): 3548, 3470, 3414, 3239, 2953, 2893, 2026, 1854, 1734, 1618
cm–1.
1H NMR (500 MHz, CDCl3): δ = 3.90 (s, 6 H), 1.46 (s, 3 H), 1.00 (br s,
2 H).
13C NMR (125 MHz, CDCl3): δ = 108.2, 72.7, 44.9, 22.9.
Anal. Calcd for C6H11NO3: C, 49.65; H, 7.64; N, 9.65. Found: C, 49.35;
H, 7.59; N, 9.46.
Preparation of Isoindoles 11a–f and 11i–k; Typical Procedure
To a solution of OPA (42.0 mg, 0.313 mmol) in anhydrous MeOH (5
mL), 1-propanethiol (31.0 μL, 0.346 mmol) and amine 5a (56.5 mg,
0.346 mmol) were added. After stirring in the dark for 3 h at r.t., the
reaction mixture was evaporated in vacuo. The oily residue was puri-
fied by column chromatography [silica gel 60N; n-hexane–EtOAc, 9:1
to 3:1] to afford isoindole 11a (69.0 mg, 65%) accompanied by the for-
mation of isoindolin-1-one 12a (16.0 mg, 18%).
2-[1,3-Dimethoxy-2-(methoxymethyl)propan-2-yl]-1-(prop-
ylthio)-2H-isoindole (11a)
Yield: 69.0 mg (65%); pale-blue solid; mp 67–68 °C.
1H NMR (500 MHz, CDCl3): δ = 7.66 (br dq, 1 H), 7.50 (br dt, 1 H), 7.44
(d, J = 0.5 Hz, 1 H), 6.99 (ddd, J = 8.5, 6.5, 0.9 Hz, 1 H), 6.91 (ddd, J =
8.4, 6.4, 0.9 Hz, 1 H), 4.21 (s, 6 H), 3.33 (s, 9 H), 2.66 (t, J = 7.4 Hz, 2 H),
1.66 (sext, J = 7.5 Hz, 2 H), 1.01 (t, J = 7.3 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 131.7, 123.1, 122.2, 120.9, 120.6,
119.1, 115.7, 109.1, 72.6, 67.8, 59.3, 41.4, 23.0, 13.6.
HRMS (ESI): m/z [M + Na]+ calcd for C18H27NO3SNa: 360.1609; found:
360.1608.
Anal. Calcd for C18H27NO3S: C, 64.06; H, 8.06; N, 4.15. Found: C, 63.76;
H, 8.09; N, 4.10.
2-[1,3-Diethoxy-2-(ethoxymethyl)propan-2-yl]-1-(propylthio)-
2H-isoindole (11b)
Yield: 122 mg (85%); pale-blue solid; mp 48–49 °C.
1H NMR (500 MHz, CDCl3): δ = 7.67 (br dq, 1 H), 7.53 (d, J = 0.6 Hz,
1 H), 7.51 (br dt, 1 H), 6.99 (ddd, J = 8.5, 6.4, 0.9 Hz, 1 H), 6.91 (ddd, J =
8.4, 6.4, 0.9 Hz, 1 H), 4.25 (s, 6 H), 3.47 (q, J = 7.0 Hz, 6 H), 2.66 (t, J =
7.4 Hz, 2 H), 1.66 (sext, J = 7.5 Hz, 2 H), 1.13 (t, J = 7.0 Hz, 9 H), 1.00 (t,
J = 7.2 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 131.7, 123.0, 122.0, 120.6, 120.5,
119.2, 116.2, 108.9, 70.5, 68.2, 66.9, 41.4, 23.0, 15.1, 13.6.
HRMS (ESI): m/z [M + Na]+ calcd for C21H33NO3SNa: 402.2079; found:
402.2076.
2-{6-[(Methoxymethoxy)methyl]-2,4,8,10-tetraoxaundecan-6-yl}-
1-(propylthio)-2H-isoindole (11c)
Yield: 91.0 mg (57%); pale-yellow oil.
1H NMR (500 MHz, CDCl3): δ = 7.67 (br dq, 1 H), 7.51–7.50 (br m,
0.5 H), 7.49–7.48 (br m, 1.5 H), 7.00 (ddd, J = 8.5, 6.5, 0.9 Hz, 1 H), 6.92
(ddd, J = 8.4, 6.5, 0.9 Hz, 1 H), 4.59 (s, 6 H), 4.43 (s, 6 H), 3.29 (s, 9 H),
2.71 (t, J = 7.4 Hz, 2 H), 1.67 (sext, J = 7.4 Hz, 2 H), 1.02 (t, J = 7.4 Hz,
3 H).
13C NMR (125 MHz, CDCl3): δ = 131.7, 123.1, 122.2, 121.0, 120.4,
119.2, 115.5, 109.4, 96.8, 67.5, 67.3, 55.5, 41.5, 22.9, 13.6.
HRMS (ESI): m/z [M + Na]+ calcd for C21H33NO6SNa: 450.1926; found:
450.1885.
2-(9-{[(2-Methoxyethoxy)methoxy]methyl}-2,5,7,11,13,16-hexa-
oxaheptadecan-9-yl)-1-(propylthio)-2H-isoindole (11d)
Yield: 113 mg (54%); pale-yellow oil.
1H NMR (500 MHz, CDCl3): δ = 7.65 (d, J = 8.6 Hz, 1 H), 7.48 (d, J =
8.3 Hz, 1 H), 7.48 (s, 1 H), 7.01–6.98 (m, 1 H), 6.93–6.90 (m, 1 H), 4.68
(s, 6 H), 4.43 (s, 6 H), 3.56–3.54 (m, 6 H), 3.49–3.47 (m, 6 H), 3.37 (s,
9 H), 2.69 (t, J = 7.4 Hz, 2 H), 1.66 (sext, J = 7.4 Hz, 2 H), 1.01 (t, J =
7.3 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 131.7, 123.0, 122.3, 121.0, 120.4,
119.2, 115.6, 109.4, 95.8, 71.7, 67.7, 67.3, 67.1, 59.0, 41.5, 23.0, 13.6.
HRMS (ESI): m/z [M + Na]+ calcd for C27H45NO9SNa: 582.2713; found:
582.2701.
2-(6-{[(Benzyloxy)methoxy]methyl}-1,11-diphenyl-2,4,8,10-tetra-
oxaundecan-6-yl)-1-(propylthio)-2H-isoindole (11e)
Yield: 148 mg (60%); orange oil.Georg Thieme Verlag  Stuttgart · New York — SynOpen 2018, 2, 50–57
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7.47 (d, J = 8.4 Hz, 1 H), 7.33–7.27 (m, 15 H), 7.01 (ddd, J = 8.5, 6.5,
0.8 Hz, 1 H), 6.93 (ddd, J = 8.3, 6.5, 0.7 Hz, 1 H), 4.72 (s, 6 H), 4.52 (s,
6 H), 4.48 (s, 6 H), 2.66 (t, J = 7.5 Hz, 2 H), 1.61 (sext, J = 7.4 Hz, 2 H),
0.94 (t, J = 7.4 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 137.6, 131.8, 128.4, 127.8, 127.7,
123.1, 122.3, 121.1, 120.4, 119.3, 115.5, 109.6, 94.9, 69.6, 67.7, 67.4,
41.5, 22.9, 13.5.
HRMS (ESI): m/z [M + Na]+ calcd for C39H45NO6SNa: 678.2865; found:
678.2883.
2-{1,7-Bis(benzyloxy)-4-[3-(benzyloxy)propyl]heptan-4-yl}-1-
(propylthio)-2H-isoindole (11f)
Yield: 224 mg (93%); pale-yellow oil.
1H NMR (500 MHz, CDCl3): δ = 7.68 (d, J = 8.5 Hz, 1 H), 7.48 (d, J =
8.4 Hz, 1 H), 7.39 (s, 1 H), 7.33–7.25 (m, 15 H), 7.03–7.00 (m, 1 H),
6.94–6.91 (m, 1 H), 4.44 (s, 6 H), 3.42 (t, J = 6.3 Hz, 6 H), 2.65 (t, J =
7.4 Hz, 2 H), 2.43–2.40 (m, 6 H), 1.60 (sext, J = 7.4 Hz, 2 H), 1.40–1.34
(m, 6 H), 0.94 (t, J = 7.4 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 138.4, 131.9, 128.3, 127.6, 127.5,
122.5, 121.9, 120.8, 120.3, 119.2, 114.3, 109.7, 72.9, 70.2, 66.9, 41.5,
32.9, 23.7, 22.8, 13.6.
HRMS (ESI): m/z [M + Na]+ calcd for C42H51NO3SNa: 672.3487; found:
672.3490.
Anal. Calcd for C42H51NO3S: C, 77.62; H, 7.91; N, 2.16. Found: C, 77.32;
H, 7.98; N, 2.13.
4-(3-Hydroxypropyl)-4-[1-(propylthio)-2H-isoindol-2-yl]heptane-
1,7-diol (11i)
Yield: 127 mg (90%); mp 116–118 °C (pale-yellow needles, CHCl3/n-
hexane).
1H NMR (500 MHz, CDCl3): δ = 7.69 (dd, J = 8.5, 0.8 Hz, 1 H), 7.50 (dt,
J = 8.4, 0.9 Hz, 1 H), 7.43 (s, 1 H), 7.03 (ddd, J = 8.5, 6.5, 0.9 Hz, 1 H),
6.94 (ddd, J = 8.4, 6.5, 0.9 Hz, 1 H), 3.62 (t, J = 6.2 Hz, 6 H), 2.71 (t, J =
7.4 Hz, 2 H), 2.45–2.42 (m, 6 H), 1.69 (sext, J = 7.4 Hz, 2 H), 1.39 (br s,
3 H), 1.36–1.30 (m, 6 H), 1.03 (t, J = 7.4 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 131.9, 122.6, 122.2, 121.0, 120.3,
119.1, 114.3, 109.5, 66.9, 62.5, 41.6, 32.5, 26.4, 22.9, 13.7.
HRMS (ESI): m/z [M + Na]+ calcd for C21H33NO3SNa: 402.2079; found:
402.2067.
2-{1,7-Bis(benzyloxy)-4-[3-(benzyloxy)propyl]heptan-4-yl}-1-(oc-
tylthio)-2H-isoindole (11j)
Yield: 206 mg (96%); pale-yellow oil.
1H NMR (500 MHz, CDCl3): δ = 7.67 (br d, 1 H), 7.48 (br d, 1 H), 7.38 (s,
1 H), 7.33–7.24 (m, 15 H), 7.01 (ddd, J = 8.5, 6.5, 0.9 Hz, 1 H), 6.93
(ddd, J = 8.4, 6.5, 0.8 Hz, 1 H), 4.44 (s, 6 H), 3.42 (t, J = 6.3 Hz, 6 H), 2.67
(t, J = 7.4 Hz, 2 H), 2.43–2.40 (m, 6 H), 1.61–1.54 (m, 2 H), 1.39–1.24
(m, 16 H), 0.88 (t, J = 7.0 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 138.4, 131.8, 128.3, 127.55, 127.48,
122.6, 121.9, 120.8, 120.3, 119.2, 114.2, 109.8, 72.9, 70.2, 66.9, 39.6,
32.9, 31.8, 29.4, 29.3, 29.2, 29.0, 23.7, 22.7, 14.1.
HRMS (ESI): m/z [M + Na]+ calcd for C47H61NO3SNa: 742.4270; found:
742.4276.
2-{1,7-Bis(benzyloxy)-4-[3-(benzyloxy)propyl]heptan-4-yl}-1-(do-
decylthio)-2H-isoindole (11k)
Yield: 210 mg (91%); pale-yellow oil.
1H NMR (500 MHz, CDCl3): δ = 7.67 (d, J = 8.6 Hz, 1 H), 7.48 (d, J =
8.4 Hz, 1 H), 7.38 (s, 1 H), 7.33–7.24 (m, 15 H), 7.03–7.00 (m, 1 H),
6.94–6.91 (m, 1 H), 4.44 (s, 6 H), 3.42 (t, J = 6.3 Hz, 6 H), 2.67 (t, J =
7.4 Hz, 2 H), 2.43–2.40 (m, 6 H), 1.60–1.54 (m, 2 H), 1.38–1.25 (m,
24 H), 0.88 (t, J = 6.9 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 138.4, 131.8, 128.3, 127.55, 127.47,
122.6, 121.9, 120.8, 120.3, 119.2, 114.2, 109.8, 72.9, 70.2, 66.9, 39.6,
32.9, 31.9, 29.7, 29.64, 29.56, 29.5, 29.38, 29.36, 29.1, 29.0, 23.7, 22.7,
14.1.
HRMS (ESI): m/z [M + Na]+ calcd for C51H69NO3SNa: 798.4896; found:
798.4892.
Anal. Calcd for C51H69NO3S: C, 78.92; H, 8.96; N, 1.80. Found: C, 78.62;
H, 9.01; N, 1.83.
2-[1,3-Dimethoxy-2-(methoxymethyl)propan-2-yl]isoindolin-1-
one (12a)
Yield: 16.0 mg (18%); white solid; mp 63.5–66.0 °C.
IR (KBr): 2976, 2876, 1684, 1471, 1383, 1304, 1103 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.78 (d, J = 7.5 Hz, 1 H), 7.51 (td, J = 7.4,
1.1 Hz, 1 H), 7.44–7.39 (m, 2 H), 4.66 (s, 2 H), 3.97 (s, 6 H), 3.35 (s,
9 H).
13C NMR (125 MHz, CDCl3): δ = 169.6, 142.1, 133.5, 131.1, 127.6,
123.2, 122.3, 71.1, 63.4, 59.3, 50.1.
HRMS (ESI): m/z [M + Na]+ calcd for C15H21NO4Na: 302.1368; found:
302.1342.
2-[1,3-Diethoxy-2-(ethoxymethyl)propan-2-yl]isoindolin-1-one 
(12b)
Yield: 14.0 mg (12%); yellow oil.
IR (neat): 2974, 2870, 1684, 1469, 1393, 1301, 1103 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.78 (d, J = 7.5 Hz, 1 H), 7.50 (td, J = 7.4,
1.1 Hz, 1 H), 7.43–7.39 (m, 2 H), 4.71 (s, 2 H), 4.03 (s, 6 H), 3.50 (q, J =
7.0 Hz, 6 H), 1.14 (t, J = 7.0 Hz, 9 H).
13C NMR (125 MHz, CDCl3): δ = 169.6, 142.2, 133.7, 130.9, 127.4,
123.2, 122.2, 68.9, 66.8, 63.6, 50.3, 15.2.
HRMS (ESI): m/z [M + Na]+ calcd for C18H27NO4Na: 344.1838; found:
344.1834.
2-{6-[(Methoxymethoxy)methyl]-2,4,8,10-tetraoxaundecan-6-
yl}isoindolin-1-one (12c)
Yield: 57.2 mg (41%); pale-yellow oil.
IR (neat): 2947, 2890, 2823, 1684, 1470, 1152, 1111, 1041 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.80 (d, J = 7.6 Hz, 1 H), 7.52 (td, J = 7.5,
1.1 Hz, 1 H), 7.45–7.39 (m, 2 H), 4.69 (s, 2 H), 4.64 (s, 6 H), 4.17 (s,
6 H), 3.33 (s, 9 H).
13C NMR (125 MHz, CDCl3): δ = 169.5, 141.9, 133.4, 131.2, 127.7,
123.3, 122.3, 96.9, 66.2, 62.8, 55.4, 50.0.
HRMS (ESI): m/z [M + Na]+ calcd for C18H27NO7Na: 392.1685; found:
392.1664.
2-(9-{[(2-Methoxyethoxy)methoxy]methyl}-2,5,7,11,13,16-hexa-
oxaheptadecan-9-yl)isoindolin-1-one (12d)
Yield: 83.2 mg (44%); pale-yellow oil.Georg Thieme Verlag  Stuttgart · New York — SynOpen 2018, 2, 50–57
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1H NMR (500 MHz, CDCl3): δ = 7.78 (d, J = 7.6 Hz, 1 H), 7.52 (td, J = 7.5,
1.1 Hz, 1 H), 7.45–7.38 (m, 2 H), 4.72 (s, 6 H), 4.66 (s, 2 H), 4.17 (s,
6 H), 3.64–3.62 (m, 6 H), 3.53–3.50 (m, 6 H), 3.37 (s, 9 H).
13C NMR (125 MHz, CDCl3): δ = 169.4, 141.9, 133.3, 131.2, 127.7,
123.2, 122.3, 96.0, 71.7, 67.0, 66.3, 62.8, 59.0, 50.0.
HRMS (ESI): m/z [M + Na]+ calcd for C24H39NO10Na: 524.2472; found:
524.2473.
2-(6-{[(Benzyloxy)methoxy]methyl}-1,11-diphenyl-2,4,8,10-tetra-
oxaundecan-6-yl)isoindolin-1-one (12e)
Yield: 87.0 mg (39%); pale-yellow oil.
IR (neat): 2943, 2886, 1684, 1454, 1383, 1169, 1112, 1044 cm–1.
1H NMR (500 MHz, CDCl3): δ = 7.79 (d, J = 7.6 Hz, 1 H), 7.51 (td, J = 7.5,
1.1 Hz, 1 H), 7.42 (t, J = 7.5 Hz, 1 H), 7.37 (d, J = 7.5 Hz, 1 H), 7.34–7.26
(m, 15 H), 4.76 (s, 6 H), 4.66 (s, 2 H), 4.55 (s, 6 H), 4.26 (s, 6 H).
13C NMR (125 MHz, CDCl3): δ = 169.5, 141.8, 137.7, 133.3, 131.2,
128.4, 127.8, 127.73, 127.67, 123.3, 122.3, 95.1, 69.5, 66.5, 62.9, 50.0.
HRMS (ESI): m/z [M + Na]+ calcd for C36H39NO7Na: 620.2624; found:
620.2635.
2-{1,7-Bis(benzyloxy)-4-[3-(benzyloxy)propyl]heptan-4-yl}isoin-
dolin-1-one (12f)
Yield: 13.0 mg (ca. 6%); pale-yellow oil.
1H NMR (500 MHz, CDCl3): δ = 7.77 (d, J = 7.5 Hz, 1 H), 7.49 (td, J = 7.4,
1.2 Hz, 1 H), 7.43 (d, J = 7.4 Hz, 1 H), 7.36–7.22 (m, 16 H), 4.47 (s, 2 H),
4.46 (s, 6 H), 3.46 (t, J = 6.7 Hz, 6 H), 2.13–2.05 (m, 6 H), 1.62–1.52 (m,
6 H).
HRMS (ESI): m/z [M + Na]+ calcd for C39H45NO4Na: 614.3246; found:
614.3204.
HPLC Equipment and Conditions
A Gulliver HPLC system (JASCO) equipped with a Rheodyne 7125 in-
jection valve (20 μL loop), UV/Vis detector (UV-970), and HPLC pump
(PU-980) was used. HPLC analysis was performed with a TSKgel ODS-
80Ts analytical column (250 × 4.6 mm id, 5 μm, Tosoh) by measuring
absorbance at 330 nm. The mobile phase was a mixture of MeOH and
water (200:1, v/v) at a flow rate of 1.0 mL min–1.
Supporting Information
Supporting information for this article is available online at
https://doi.org/10.1055/s-0036-1591932. Suporting IformationSuporting Iformation
References
(1) Burford, K. N. Isoindole, In e-EROS Encyclopedia of Reagents for
Organic Synthesis; Wiley: New York, 2015.
(2) (a) Roth, M. Anal. Chem. 1971, 43, 880. (b) Zuman, P. Chem. Rev.
2004, 104, 3217.
(3) (a) Liu, H. In Methods in Molecular Biology;Vol. 159 Cooper, C.; Packer,
N.; Williams, K., Eds.; Humana Press: Totowa, NJ, 2001, 123.
(b) Hermanson, G. T. In Bioconjugate Techniques, 2nd ed.; Else-
vier: London, 2008, 128.
(4) (a) Gardner, W. S.; Miller, W. H. Anal. Biochem. 1980, 101, 61.
(b) Godel, H.; Graser, T.; Földi, P.; Pfaender, P.; Fürst, P. J. Chro-
matogr. A 1984, 297, 49. (c) Lookhart, G. L.; Jones, B. L. Cereal
Chem. 1985, 62, 97. (d) Dorresteijn, R. C.; Berwald, L. G.; Zomer,
G.; de Gooijer, C. D.; Wieten, G.; Beuvery, E. C. J. Chromatogr. A
1996, 724, 159. (e) Lázaro de la Torre, C. A.; Conte-Júnior, C. A.
Braz. J. Vet. Res. Anim. Sci. 2013, 50, 430. (f) Borowczyk, K.;
Chwatko, G.; Kubalczyk, P.; Jakubowski, H.; Kubalska, J.;
Głowacki, R. Talanta 2016, 161, 917. (g) Douša, M.; Pivoňková,
V.; Sýkora, D. J. Sep. Sci. 2016, 39, 3145.
(5) (a) Nakamura, H.; Matsumoto, A.; Tamura, Z. Anal. Lett. 1982,
15, 1393. (b) Stobaugh, J. F.; Repta, A. J.; Sternson, L. A.; Garren,
K. W. Anal. Biochem. 1983, 135, 495. (c) Jacobs, W. A.; Leburg, M.
W.; Madaj, E. J. Anal. Biochem. 1986, 156, 334. (d) Stobaugh, J. F.;
Repta, A. J.; Sternson, L. A. J. Pharm. Biomed. Anal. 1986, 4, 341.
(e) García Alvarez-Coque, M. C.; Medina Hernández, M. J.;
Villanueva Camañas, R. M.; Mongay Fernández, C. Anal. Bio-
chem. 1989, 178, 1. (f) Dai, F.; Burkert, V. P.; Singh, H. N.; Hinze,
W. L. Microchem. J. 1997, 57, 166. (g) Heugebaert, T. S. A.;
Roman, B. I.; Stevens, C. V. Chem. Soc. Rev. 2012, 41, 5626.
(6) (a) West, R.; Fink, M. J.; Michl, J. Science 1981, 214, 1343.
(b) Yoshifuji, M.; Shima, I.; Inamoto, N.; Hirotsu, K.; Higuchi, T.
J. Am. Chem. Soc. 1981, 103, 4587.
(7) (a) Okazaki, R.; West, R. Adv. Organomet. Chem. 1996, 39, 231.
(b) Power, P. P. Chem. Rev. 1999, 99, 3463. (c) Tokitoh, N. Acc.
Chem. Res. 2004, 37, 86. (d) Kira, M.; Iwamoto, T. Adv.
Organomet. Chem. 2006, 54, 73. (e) Mizuhata, Y.; Sasamori, T.;
Tokitoh, N. Chem. Rev. 2009, 109, 3479. (f) Wang, Y.; Robinson,
G. H. Chem. Commun. 2009, 5201. (g) Fischer, R. C.; Power, P. P.
Chem. Rev. 2010, 110, 3877. (h) Scheschkewitz, D. Chem. Lett.
2011, 40, 2. (i) Asay, M.; Sekiguchi, A. Bull. Chem. Soc. Jpn. 2012,
85, 1245. (j) Sasamori, T.; Tokitoh, N. Bull. Chem. Soc. Jpn. 2013,
86, 1005. (k) Yoshifuji, M. Eur. J. Inorg. Chem. 2016, 607.
(l) Yoshifuji, M. Phosphorus, Sulfur, Silicon Relat. Elem. 2016, 191,
1452.
(8) (a) Sipos, A.; Török, Z.; Röth, E.; Kiss-Szikszai, A.; Batta, G.;
Bereczki, I.; Fejes, Z.; Borbás, A.; Ostorházi, E.; Rozgonyi, F.;
Naesens, L.; Herczegh, P. Bioorg. Med. Chem. Lett. 2012, 22, 7092.
(b) Sipos, A.; Máté, G.; Röth, E.; Borbás, A.; Batta, G.; Bereczki, I.;
Kéki, S.; Jóna, I.; Ostorházi, E.; Rozgonyi, F.; Vanderlinden, E.;
Naesens, L.; Herczegh, P. Eur. J. Med. Chem. 2012, 58, 361.
(9) (a) Tonhauser, C.; Schüll, C.; Dingels, C.; Frey, H. ACS Macro Lett.
2012, 1, 1094. (b) Schüll, C.; Nuhn, L.; Mangold, C.; Christ, E.;
Zentel, R.; Frey, H. Macromolecules 2012, 45, 5901.
(10) (a) Segura, M.; Sansone, F.; Casnati, A.; Ungaro, R. Synthesis
2001, 2105. (b) Pasha, A.; Lin, M.; Tircsó, G.; Rostollan, C. L.;
Woods, M.; Kiefer, G. E.; Sherry, A. D.; Sun, X. J. Biol. Inorg. Chem.
2009, 14, 421. (c) Chen, Z.; Hu, W.; Wang, M.; Wang, L.; Su, G.;
Wang, J. Carbohydr. Res. 2016, 429, 81. (d) Das, R.;
Mukhopadhyay, B. Tetrahedron Lett. 2016, 57, 1775.
(11) Bundy, G. L.; Pals, D. T.; Lawson, J. A.; Couch, S. J.; Lipton, M. F.;
Mauragis, M. A. J. Med. Chem. 1990, 33, 2276.Georg Thieme Verlag  Stuttgart · New York — SynOpen 2018, 2, 50–57
